Low Oxygen Therapy for Spinal Cord Injury
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether low oxygen therapy (LOT) can stabilize blood pressure in individuals with long-term spinal cord injuries. Participants will breathe lower oxygen levels for short periods, potentially boosting the nervous system and improving heart and blood vessel functions. The researchers aim to find ways to lower heart disease risk in those with spinal cord injuries. This trial may suit someone with a spinal cord injury at or above the T1 level, who has lived with it for over a year and does not have additional neurological conditions. As a Phase 1 and Phase 2 trial, this research focuses on understanding how the treatment works and measuring its effectiveness in an initial, smaller group, offering participants a chance to contribute to groundbreaking medical advancements.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the research team for guidance.
What prior data suggests that low oxygen therapy is safe for individuals with spinal cord injury?
Research is exploring low oxygen therapy (LOT) for its potential benefits, but sufficient information about its safety is not yet available. This trial is in the early stages, focusing on how well participants tolerate the treatment and what side effects might occur.
While LOT remains unproven, another oxygen-based treatment, hyperbaric oxygen therapy, has shown promise in similar contexts. Studies suggest it could be a safe and effective option for spinal cord injury, though it differs from LOT.
As this trial is in the early stages, further research is necessary to fully understand LOT's safety. Participants in this study will contribute to learning more about the therapy's safety and tolerability. Those considering joining the trial should discuss potential risks and benefits with the research team.12345Why do researchers think this study treatment might be promising?
Researchers are excited about Low Oxygen Therapy (LOT) for spinal cord injury because it offers a fresh approach by using intermittent low oxygen levels to promote recovery. Unlike standard treatments, which generally focus on physical therapy and medication management to improve function and reduce symptoms, LOT potentially triggers the body's adaptive responses to low oxygen, which might aid nerve regeneration and repair. Additionally, this therapy is non-invasive and could provide benefits within a short duration, making it a promising addition to current treatment options.
What evidence suggests that low oxygen therapy might be an effective treatment for spinal cord injury?
Research has shown that low oxygen therapy (LOT), which participants in this trial will receive, might help stabilize blood pressure in people with spinal cord injuries. Early results suggest that breathing air with less oxygen can boost the body's autonomic nervous system, which controls heart rate and blood pressure. Although direct evidence on blood pressure improvements from LOT remains limited, its potential to enhance autonomic function offers hope for managing heart and blood pressure risks in this group.23467
Are You a Good Fit for This Trial?
This trial is for individuals aged 19-65 living with a chronic cervical spinal cord injury at or above T1 level for at least one year and who are fluent in English.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Measurements taken at least three days before the intervention to establish baseline characteristics
Treatment
Participants undergo a 4-day low oxygen therapy intervention
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments immediately after the first intervention session, and at 1-day and 4-days post-intervention
What Are the Treatments Tested in This Trial?
Interventions
- Low Oxygen Therapy (LOT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Glen Foster
Lead Sponsor